This study evaluated the rates of dose escalation in patients with Crohn's disease.
An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Copay organizations play an important role in helping patients obtain their medications and have become integral partner with specialty pharmacies as they work together to support different therapies.
Myasthenia gravis (MG) is an autoimmune-mediated neuromuscular disease characterized by muscle weakness.
The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.
Healthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.
A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
The City Council Committee on Finance approved a measure that restricts pharmacists to filling orders for no more than 10 patients per hour.
The emergence of a new Medicare Advantage plan, Troy Medicare, offers much needed momentum to drive pharmacists’ services.
Selection of optimal antibiotic therapy is crucial in the treatment of MRSA.
Guilty plea relates to shortcomings in recordkeeping of controlled substances 10 years earlier.
Home infusion of teprotumumab-trbw (Tepezza), a breakthrough treatment for thyroid eye disease, was found to effectively minimize the chance of infection with coronavirus disease 2019 for both patients and staff of Chartwell Pennsylvania, LP.
Organ transplants from seropositive donors carry a high risk of infection from the transplanted organ.
Social media can help pharmacists take control over their brand image.
The American Diabetes Association recommends that health care providers incorporate an estimated average glucose measurement when counseling patients with diabetes.
This study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.
Executive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.
Adherence to risperidone long-acting injection (RLAI) therapy in the outpatient setting was poor. Degree of discharge planning from inpatient hospitalization was not associated with RLAI adherence.
Study results have demonstrated that pharmacists are effective partners in improving care, reducing cost, and avoiding drug complications for patients with cancer.
A retailer's decision to get involved in the specialty pharmacy marketplace should be an informed one that encompasses careful research and a full understanding of all of the stakeholder requirements.
Patients with this severe condition seem to experience significant differences in quality of life despite having similar visual fields
The Food and Drug Administration Safety and Innovation Act was signed into law in 2012, but the crisis continues.
A controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.
Patients can benefit significantly by having support throughout their treatment journey, starting with access and minimizing financial barriers.